（Boston Orange編譯）東北微電子聯盟（NEMC）7月7日宣佈，將首度和美國陸軍作戰能力發展司令部（DEVCOM）合作，藉「BioNexus：麻州生物技術和生物製造補助項目（BioNexus: Massachusetts Biotechnology and Biomanufacturing grant program）」，給麻州的企業、學研究機構提供最高300萬美元資金，開發解決方案。
BioNexus 要把東北微電子聯盟（ NEMC ）的成功模式——精準對接研究人員、新創公司、製造商與聯邦國防領域的挑戰需求，從微電子領域擴大應用到生物技術與生物製造領域，將聚焦於解決美陸軍作戰能力發展司令部（DEVCOM）所提出的10項具體技術挑戰，涵蓋範疇從單兵作戰營養、戰場生物感測，到軍事裝備專用的生物衍生材料等，加速技術從實驗室研發，走向實際應用。
麻州州長奚莉（Maura Healey）與副州長Kim Driscoll均指出，該計畫將鞏固麻州在生技與生命科學領域的領先地位，同時強化國家安全，強化經濟、為基層勞工與企業創造機會。東北微電子聯盟（NEMC）總監馬克·哈夫曼（Mark Halfman）與麻州經濟發展廳長艾瑞克·佩利（Eric Paley）強調，這將為深科技（Deep-tech）研發與實際應用搭起有效橋樑。
麻州技術協作中心（MassTech）麾下的東北微電子聯盟（NEMC）和DEVCOM的高層，6月30日時，已在劍橋市的LabCentral舉辦過一場「BioNexus提案者日 （Proposer’s Day）」，邀集150多名麻州生物技術，生命科學的研究及國防公司，審議這項目的技術優先順序，申請條件，以及合作機會。
7月2日時，麻州政府也公佈了彙整1000多名相關學者、專家意見後起草的「國防創新、交流與領導戰略中心（SHIELD）』報告，指陳應充分利用麻州國防創新生態系統所面對的關鍵挑戰與機會。報告提出了一項核心建議，就是在麻州技術協作中心（MassTech）旗下整合兩項相輔相成的使命：一是 NEMC 推動關鍵技術從研發走向部署的聯邦職責，二是動用「麻州贏法案（Mass Wins Act）」中所提議的1億美元資金，來落實「 SHIELD 」方案，促進經濟發展的使命。
有意申請BioNexus項目補助款的單位，需在7月17日前遞交白皮書（意向書/初審提案），完整提案要求及申請資訊，可在NEMC官網上查詢。
New BioNexus Program Expands Northeast Microelectronics Coalition Mission
NEMC builds on successful track record of accelerating critical microelectronics from development to deployment with expansion into biomanufacturing and beyond
BOSTON – The Northeast Microelectronics Coalition (NEMC), a division of the Massachusetts Technology Collaborative (MassTech), today launched a major expansion of its role in the region’s defense sector ecosystem through the BioNexus: Massachusetts Biotechnology and Biomanufacturing grant program, which will provide up to $3 million to Massachusetts companies, universities and research institutions to develop biotechnology and biomanufacturing solutions for the U.S. Army Combat Capabilities Development Command (DEVCOM).
BioNexus expands NEMC's successful model of connecting researchers, startups and manufacturers with federal defense challenges beyond microelectronics and into biotechnology and biomanufacturing, helping accelerate new technologies from research to real-world deployment.
"Massachusetts has long been a leader in biotechnology and life sciences, and BioNexus builds on that foundation by creating new opportunities for our researchers, entrepreneurs and companies," said Governor Maura Healey. "This partnership will help bring innovative technologies to market faster, create jobs, strengthen our economy and support our national security."
"Massachusetts has a long history of solving big challenges through innovation, and BioNexus builds on that tradition," said Lieutenant Governor Kim Driscoll. "This program will bring together researchers, startups and manufacturers to develop technologies that support the military while creating new opportunities for businesses and workers across Massachusetts."
The announcement coincides with the release last week of the Strategic Hub for Innovation, Exchange and Leadership in Defense (SHIELD) report. Drafted by the SHIELD Working Group with input from more than 1,000 Massachusetts stakeholders, the report identifies key challenges and opportunities to strengthen the state's defense innovation ecosystem. A core recommendation in the report is to unify two complementary missions under MassTech: NEMC’s federal mandate to advance critical technologies from development to deployment and SHIELD’s economic development mission.
The state will leverage federal matching funds and $100 million of proposed funding in the Mass Wins Act to operationalize the recommendations in the SHIELD Report.
"NEMC has demonstrated that Massachusetts can successfully connect federal priorities with the talent and innovation happening across our research institutions and private sector," said Economic Development Secretary Eric Paley. "BioNexus expands that model into biotechnology and biomanufacturing, creating new opportunities for Massachusetts companies and researchers to help solve critical defense challenges while growing an industry where our state already leads."
On Tuesday, June 30, NEMC and leaders from DEVCOM hosted a BioNexus Proposer’s Day at LabCentral in Cambridge. The event brought together more than 150 participants from across the Massachusetts biotechnology, life sciences, research and defense communities to review the program’s technical priorities, application requirements and teaming opportunities.
Expanding access to additional defense sponsors, BioNexus marks NEMC’s first program in partnership with DEVCOM and extends its proven operating model beyond microelectronics into biotechnology and biomanufacturing. The program offers funding to address 10 DEVCOM-defined challenges ranging from warfighter nutrition and field biosensing to bio-derived materials for military equipment.
“The BioNexus program further demonstrates NEMC’s commitment to accelerating translational innovation across critical deep-tech sectors and bridging the gap between research and development and real-world applications,” said NEMC Director Mark Halfman. “We look forward to engaging Massachusetts' world-class life sciences and research ecosystem to address DEVCOM challenges in biotechnology and biomanufacturing”
BioNexus white paper applications are due July 17, 2026. The complete Call for Projects and application information are available on the NEMC website.
沒有留言:
發佈留言